Inhibiting mTOR means increasing immunosurveillance [65,66], as mTOR modulates the relationship between the tumor microenvironment, which includes the immune system cells (macrophages, natural killer cells, neutrophils, helper T lymphocytes, cytotoxic T lymphocytes, regulatory T lymphocytes), and cancer cells [62,67]. Here, MTOR is linked to cancer.